Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.32 USD | +1.55% | -1.48% | -11.34% |
05-14 | Stephens Initiates Exelixis With Equalweight Rating, $23 Price Target | MT |
05-10 | Exelixis Files Patent Complaint Against Cipla's Cancer Treatment | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.34% | 6.11B | |
+6.68% | 111B | |
+10.99% | 106B | |
-13.09% | 22.24B | |
+0.55% | 21.25B | |
-4.13% | 18.97B | |
-37.85% | 18.52B | |
-10.50% | 16.81B | |
+39.11% | 12.54B | |
-24.76% | 8.09B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Exelixis Appoints Amy Peterson as Chief Medical Officer